Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-07-05
2011-11-22
Moore, Susanna (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S253000
Reexamination Certificate
active
08063050
ABSTRACT:
The present invention provides compounds, including resolved enantiomers, resolved diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the Formula I:Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
REFERENCES:
patent: 3885035 (1975-05-01), Simpson
patent: 3956495 (1976-05-01), Lacefield
patent: 3966936 (1976-06-01), Cronin et al.
patent: 4060615 (1977-11-01), Matier et al.
patent: 4352928 (1982-10-01), Hiranuma et al.
patent: 5051412 (1991-09-01), Macor
patent: 5525625 (1996-06-01), Bridges et al.
patent: 5563152 (1996-10-01), Kulagowski et al.
patent: 5610303 (1997-03-01), Kimura et al.
patent: 5750531 (1998-05-01), Lee et al.
patent: 5750545 (1998-05-01), Akahoshi et al.
patent: 5817671 (1998-10-01), Filla et al.
patent: 6310060 (2001-10-01), Barrett et al.
patent: 6423716 (2002-07-01), Matsuno et al.
patent: 6469004 (2002-10-01), Barrett et al.
patent: 6506798 (2003-01-01), Barrett et al.
patent: 6627628 (2003-09-01), Schindler et al.
patent: 6831175 (2004-12-01), Li et al.
patent: 7041687 (2006-05-01), Binch et al.
patent: 7067664 (2006-06-01), Chen
patent: 7115741 (2006-10-01), Levy et al.
patent: 7125880 (2006-10-01), Chen
patent: 7223738 (2007-05-01), Bilodeau et al.
patent: 7223767 (2007-05-01), Clark et al.
patent: 2003/0004193 (2003-01-01), Barrett et al.
patent: 2003/0045521 (2003-03-01), Tecle
patent: 2003/0078428 (2003-04-01), Barrett et al.
patent: 2003/0092748 (2003-05-01), Barrett et al.
patent: 2003/0199511 (2003-10-01), Li et al.
patent: 2003/0216460 (2003-11-01), Wallace et al.
patent: 2003/0232869 (2003-12-01), Wallace et al.
patent: 2004/0053933 (2004-03-01), Pontillo et al.
patent: 2004/0102360 (2004-05-01), Barnett et al.
patent: 2004/0116710 (2004-06-01), Wallace et al.
patent: 2004/0176400 (2004-09-01), Capelli et al.
patent: 2005/0059687 (2005-03-01), Makings et al.
patent: 2005/0130954 (2005-06-01), Mitchell et al.
patent: 2005/0182061 (2005-08-01), Green et al.
patent: 2006/0025074 (2006-02-01), Liang et al.
patent: 2006/0062400 (2006-03-01), Chia-Chun
patent: 2007/0004708 (2007-01-01), Andreotti et al.
patent: 2007/0027156 (2007-02-01), Nakai et al.
patent: 2007/0135466 (2007-06-01), Ledeboer et al.
patent: 2008/0076774 (2008-03-01), Anand et al.
patent: 2008/0188482 (2008-08-01), Rice et al.
patent: 194161 (1986-09-01), None
patent: 95/03286 (1995-02-01), None
patent: 98/43960 (1998-10-01), None
patent: 99/01421 (1999-01-01), None
patent: 99/01426 (1999-01-01), None
patent: 00/40235 (2000-07-01), None
patent: 00/40237 (2000-07-01), None
patent: 00/41505 (2000-07-01), None
patent: 00/41994 (2000-07-01), None
patent: 00/42002 (2000-07-01), None
patent: 00/42003 (2000-07-01), None
patent: 00/42022 (2000-07-01), None
patent: 00/42029 (2000-07-01), None
patent: 00/68201 (2000-11-01), None
patent: 01/05390 (2001-01-01), None
patent: 01/05391 (2001-01-01), None
patent: 01/05392 (2001-01-01), None
patent: 01/05393 (2001-01-01), None
patent: 01/68619 (2001-09-01), None
patent: 02/06213 (2002-01-01), None
patent: 02/18319 (2002-03-01), None
patent: 02/44166 (2002-06-01), None
patent: 02/083139 (2002-10-01), None
patent: 03/022214 (2003-03-01), None
patent: 03/064397 (2003-08-01), None
patent: 03/077855 (2003-09-01), None
patent: 03/077914 (2003-09-01), None
patent: 03/086279 (2003-10-01), None
patent: 03/086394 (2003-10-01), None
patent: 03/086403 (2003-10-01), None
patent: 03/086404 (2003-10-01), None
patent: 03/094918 (2003-11-01), None
patent: 2004/041162 (2004-05-01), None
patent: 2004/096130 (2004-11-01), None
patent: 2005/014558 (2005-02-01), None
patent: 2005/117909 (2005-12-01), None
patent: 2006/046023 (2006-05-01), None
patent: 2006/071819 (2006-07-01), None
patent: 2006/090261 (2006-08-01), None
patent: 2006/136830 (2006-12-01), None
patent: WO 2007042298 (2007-04-01), None
patent: WO 2007077961 (2007-07-01), None
patent: 2007/125320 (2007-11-01), None
patent: 2008/012635 (2008-01-01), None
patent: WO 2008003697 (2008-01-01), None
patent: WO 2008003958 (2008-01-01), None
patent: WO 2008003978 (2008-01-01), None
patent: WO 2008005511 (2008-01-01), None
patent: WO 2008005964 (2008-01-01), None
patent: WO 2008006032 (2008-01-01), None
patent: WO 2008006040 (2008-01-01), None
Vippagunta, S.R., (Adv. Drug. Delivery Rev., 2001, 48, pp. 3-26).
Truong, T. N., “Office Action for U.S. Appl. No. 10/993,173”, United States Patent and Trademark Office, Aug. 6, 2008, 8 pages.
Truong, T. N., “Office Action for U.S. Appl. No. 10/993,173”, United States Patent and Trademark Office, May 26, 2009, 8 pages.
Patent Cooperation Treaty, “International Search Report and Written Opinion of the International Searching Authority”, PCT/US2007/072885, Dec. 3, 2007, 10 pages.
Ohno, S., et al., “Synthesis and Hypoglycemic Activity of 7,8-Dihydro-6H-thiopyrano[3,2-d]pyrimidine Derivatives and Related Compounds”, Chem. Pharm. Bull., 1986, 34(10), 4150-4165.
Zhao, Z., et al., “Discovery of 2,3,5-trisubstituted pyridine derivatives as potent Akt1 and Akt2 dual inhibitors”, Bioorg. Med. Chem. Lett., 2005, 15, 905-909.
Ross, L., et al., “Potential Anticancer Agents. XVIII. Synthesis of Substituted 4,5-Trimethylenepyrimidines”, J. Am. Chem. Soc., 1959, 81, 3108-3113.
Li, Qun “Expert Opinion: Recent Progress in the Discovery of Akt Inhibitors as Anticancer Agents”, Informa Healthcare, 2007, 17(9), pp. 1077-1130.
Banka Anna L.
Bencsik Josef R.
Blake James F.
Chabot Christine
Do Steven
Array BioPharma Inc.
Covenentech, Inc.
Moore Susanna
Viksnins Harris & Padys PLLP
LandOfFree
Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4276126